BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 22153071)

  • 21. Incompatibility of the circadian protein BMAL1 and HNF4α in hepatocellular carcinoma.
    Fekry B; Ribas-Latre A; Baumgartner C; Deans JR; Kwok C; Patel P; Fu L; Berdeaux R; Sun K; Kolonin MG; Wang SH; Yoo SH; Sladek FM; Eckel-Mahan K
    Nat Commun; 2018 Oct; 9(1):4349. PubMed ID: 30341289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutual amplification of HNF4α and IL-1R1 composes an inflammatory circuit in Helicobacter pylori associated gastric carcinogenesis.
    Ma L; Zeng J; Guo Q; Liang X; Shen L; Li S; Sun Y; Li W; Liu S; Yu H; Chen C; Jia J
    Oncotarget; 2016 Mar; 7(10):11349-63. PubMed ID: 26870992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
    Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
    Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Underexpressed coactivators PGC1alpha and SRC1 impair hepatocyte nuclear factor 4 alpha function and promote dedifferentiation in human hepatoma cells.
    Martínez-Jiménez CP; Gómez-Lechón MJ; Castell JV; Jover R
    J Biol Chem; 2006 Oct; 281(40):29840-9. PubMed ID: 16891307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EPS15R, TASP1, and PRPF3 are novel disease candidate genes targeted by HNF4alpha splice variants in hepatocellular carcinomas.
    Niehof M; Borlak J
    Gastroenterology; 2008 Apr; 134(4):1191-202. PubMed ID: 18395097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cooperative interaction between hepatocyte nuclear factor 4 alpha and GATA transcription factors regulates ATP-binding cassette sterol transporters ABCG5 and ABCG8.
    Sumi K; Tanaka T; Uchida A; Magoori K; Urashima Y; Ohashi R; Ohguchi H; Okamura M; Kudo H; Daigo K; Maejima T; Kojima N; Sakakibara I; Jiang S; Hasegawa G; Kim I; Osborne TF; Naito M; Gonzalez FJ; Hamakubo T; Kodama T; Sakai J
    Mol Cell Biol; 2007 Jun; 27(12):4248-60. PubMed ID: 17403900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pro-apoptotic role of the regulatory feedback loop between miR-124 and PKM1/HNF4α in colorectal cancer cells.
    Sun Y; Zhao X; Luo M; Zhou Y; Ren W; Wu K; Li X; Shen J; Hu Y
    Int J Mol Sci; 2014 Mar; 15(3):4318-32. PubMed ID: 24619225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCAAT-enhancer binding protein-α (C/EBPα) and hepatocyte nuclear factor 4α (HNF4α) regulate expression of the human fructose-1,6-bisphosphatase 1 (FBP1) gene in human hepatocellular carcinoma HepG2 cells.
    Wattanavanitchakorn S; Rojvirat P; Chavalit T; MacDonald MJ; Jitrapakdee S
    PLoS One; 2018; 13(3):e0194252. PubMed ID: 29566023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xenosensor CAR mediates down-regulation of miR-122 and up-regulation of miR-122 targets in the liver.
    Kazantseva YA; Yarushkin AA; Mostovich LA; Pustylnyak YA; Pustylnyak VO
    Toxicol Appl Pharmacol; 2015 Oct; 288(1):26-32. PubMed ID: 26171734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling.
    Zhang Y; Wei W; Cheng N; Wang K; Li B; Jiang X; Sun S
    Hepatology; 2012 Nov; 56(5):1631-40. PubMed ID: 22610915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
    Huang B; Huang M; Li Q
    Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene.
    Maeda Y; Hwang-Verslues WW; Wei G; Fukazawa T; Durbin ML; Owen LB; Liu X; Sladek FM
    Biochem J; 2006 Dec; 400(2):303-13. PubMed ID: 16895524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
    Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J
    J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HNF4α-Deficient Fatty Liver Provides a Permissive Environment for Sex-Independent Hepatocellular Carcinoma.
    Fekry B; Ribas-Latre A; Baumgartner C; Mohamed AMT; Kolonin MG; Sladek FM; Younes M; Eckel-Mahan KL
    Cancer Res; 2019 Nov; 79(22):5860-5873. PubMed ID: 31575546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of mitogenic and motogenic pathways by miR-198, diminishing hepatoma cell growth and migration.
    Elfimova N; Sievers E; Eischeid H; Kwiecinski M; Noetel A; Hunt H; Becker D; Frommolt P; Quasdorff M; Steffen HM; Nürnberg P; Büttner R; Teufel A; Dienes HP; Drebber U; Odenthal M
    Biochim Biophys Acta; 2013 May; 1833(5):1190-8. PubMed ID: 23391410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CXCR7 correlates with the differentiation of hepatocellular carcinoma and suppresses HNF4α expression through the ERK pathway.
    Xue TC; Jia QA; Bu Y; Chen RX; Cui JF; Tang ZY; Ye SL
    Oncol Rep; 2014 Dec; 32(6):2387-96. PubMed ID: 25242412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Celecoxib inhibits interleukin-6/interleukin-6 receptor-induced JAK2/STAT3 phosphorylation in human hepatocellular carcinoma cells.
    Liu Y; Liu A; Li H; Li C; Lin J
    Cancer Prev Res (Phila); 2011 Aug; 4(8):1296-305. PubMed ID: 21490132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatocyte nuclear factor 4 (HNF4) in epithelial development and carcinogenesis].
    Lazarevich NL; Al'pern DV
    Mol Biol (Mosk); 2008; 42(5):786-97. PubMed ID: 18988528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway.
    Wang J; Lu L; Luo Z; Li W; Lu Y; Tang Q; Pu J
    Biomed Pharmacother; 2019 Dec; 120():109551. PubMed ID: 31648164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.